{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:46:42Z","timestamp":1791600402667,"version":"4.3.4"},"reference-count":231,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,1]]},"DOI":"10.1210\/er.2015-1114","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T18:06:55Z","timestamp":1498241215000},"page":"325-350","source":"Crossref","is-referenced-by-count":251,"title":["Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned"],"prefix":"10.1210","volume":"38","author":[{"given":"Matthew T","family":"Drake","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Kogod Center on Aging, Mayo Clinic College of Medicine, Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart L","family":"Clarke","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Kogod Center on Aging, Mayo Clinic College of Medicine, Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merry Jo","family":"Oursler","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Kogod Center on Aging, Mayo Clinic College of Medicine, Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundeep","family":"Khosla","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Kogod Center on Aging, Mayo Clinic College of Medicine, Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,6,23]]},"reference":[{"issue":"143","key":"2019041200510708200_B1","first-page":"227","article-title":"Treatment of osteoporoses by manipulation of coherent bone cell populations","author":"Frost","year":"1979","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"2019041200510708200_B2","first-page":"3","article-title":"A 2003 update of bone physiology and Wolff\u2019s Law for clinicians","volume":"74","author":"Frost","year":"2004","journal-title":"Angle Orthod"},{"key":"2019041200510708200_B3","first-page":"273","article-title":"Morphological basis of bone mineral measurements: transient and steady state effects of treatment in osteoporosis","volume":"4","author":"Parfitt","year":"1980","journal-title":"Miner Electrolyte Metab"},{"issue":"1","key":"2019041200510708200_B4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ajpath.2013.03.006","article-title":"Understanding coupling between bone resorption and formation: are reversal cells the missing link?","volume":"183","author":"Andersen","year":"2013","journal-title":"Am J Pathol"},{"issue":"983","key":"2019041200510708200_B5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/206489a0","article-title":"Suggested sequential mode of control of changes in cell behaviour in adult bone remodelling","volume":"206","author":"Hattner","year":"1965","journal-title":"Nature"},{"issue":"1","key":"2019041200510708200_B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0221-8747(82)90002-9","article-title":"The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis","volume":"4","author":"Parfitt","year":"1982","journal-title":"Metab Bone Dis Relat Res"},{"issue":"4","key":"2019041200510708200_B7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/edrv-7-4-379","article-title":"Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease","volume":"7","author":"Eriksen","year":"1986","journal-title":"Endocr Rev"},{"issue":"11","key":"2019041200510708200_B8","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.tem.2012.03.008","article-title":"Estrogen and the skeleton","volume":"23","author":"Khosla","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"2019041200510708200_B9","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1016\/j.bbagen.2014.03.017","article-title":"Cysteine cathepsins and extracellular matrix degradation","volume":"1840","author":"Fonovic","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"2019041200510708200_B10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.biochi.2007.07.024","article-title":"Cysteine cathepsins: cellular roadmap to different functions","volume":"90","author":"Brix","year":"2008","journal-title":"Biochimie"},{"issue":"2","key":"2019041200510708200_B11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S8756-3282(96)00351-1","article-title":"Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry","volume":"20","author":"Littlewood-Evans","year":"1997","journal-title":"Bone"},{"issue":"6","key":"2019041200510708200_B12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S8756-3282(98)00138-0","article-title":"Study of immunoelectron microscopic localization of cathepsin K in osteoclasts and other bone cells in the mouse femur","volume":"23","author":"Yamaza","year":"1998","journal-title":"Bone"},{"key":"2019041200510708200_B13","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1359\/jbmr.2001.16.3.478","article-title":"Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorption","volume":"16","author":"Dodds","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2019041200510708200_B14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/jcp.10253","article-title":"Identification of cathepsin K as a novel marker of adiposity in white adipose tissue","volume":"195","author":"Chiellini","year":"2003","journal-title":"J Cell Physiol"},{"issue":"7","key":"2019041200510708200_B15","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1600-0625.2009.00855.x","article-title":"Expression and regulation of cathepsin K in skin fibroblasts","volume":"18","author":"Quintanilla-Dieck","year":"2009","journal-title":"Exp Dermatol"},{"issue":"1","key":"2019041200510708200_B16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.1013","article-title":"Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone","volume":"206","author":"Inaoka","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041200510708200_B17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/0-306-46826-3_30","article-title":"Cathepsin K expression in human lung","volume":"477","author":"B\u00fchling","year":"2000","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"2019041200510708200_B18","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1172\/JCI181","article-title":"Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells","volume":"102","author":"Sukhova","year":"1998","journal-title":"J Clin Invest"},{"issue":"6","key":"2019041200510708200_B19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1515\/bchm3.1995.376.6.379","article-title":"Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution","volume":"376","author":"Br\u00f6mme","year":"1995","journal-title":"Biol Chem Hoppe Seyler"},{"issue":"11","key":"2019041200510708200_B20","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1172\/JCI15990","article-title":"Thyroid functions of mouse cathepsins B, K, and L","volume":"111","author":"Friedrichs","year":"2003","journal-title":"J Clin Invest"},{"issue":"8","key":"2019041200510708200_B21","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/rheumatology\/ket184","article-title":"Expression of cathepsin K and tartrate-resistant acid phosphatase is not confined to osteoclasts but is a general feature of multinucleated giant cells: systematic analysis","volume":"52","author":"Park","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"2019041200510708200_B22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jor.23005","article-title":"Increased expression and activation of cathepsin K in human osteoarthritic cartilage and synovial tissues","volume":"34","author":"Kozawa","year":"2016","journal-title":"J Orthop Res"},{"issue":"6","key":"2019041200510708200_B23","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.bone.2005.10.017","article-title":"Human osteoblasts produce cathepsin K","volume":"38","author":"Mandelin","year":"2006","journal-title":"Bone"},{"issue":"23","key":"2019041200510708200_B24","first-page":"5386","article-title":"The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma","volume":"57","author":"Littlewood-Evans","year":"1997","journal-title":"Cancer Res"},{"key":"2019041200510708200_B25","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1359\/jbmr.2003.18.2.222","article-title":"Cathepsin K mRNA and protein expression in prostate cancer progression","volume":"18","author":"Brubaker","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2019041200510708200_B26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1006\/geno.1997.4631","article-title":"Structure and chromosomal assignment of the human cathepsin K gene","volume":"41","author":"Gelb","year":"1997","journal-title":"Genomics"},{"key":"2019041200510708200_B27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1196\/annals.1346.018","article-title":"The regulation of cathepsin K gene expression","volume":"1068","author":"Troen","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"2019041200510708200_B28","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1074\/jbc.M704915200","article-title":"Cathepsins B, K, and L are regulated by a defined collagen type II peptide via activation of classical protein kinase C and p38 MAP kinase in articular chondrocytes","volume":"283","author":"Ruettger","year":"2008","journal-title":"J Biol Chem"},{"issue":"10","key":"2019041200510708200_B29","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1073\/pnas.091479298","article-title":"Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family","volume":"98","author":"Motyckova","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2019041200510708200_B30","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bbrc.2004.12.005","article-title":"RANK ligand and interferon gamma differentially regulate cathepsin gene expression in pre-osteoclastic cells","volume":"328","author":"Pang","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"2019041200510708200_B31","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1074\/jbc.271.4.2126","article-title":"Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts: functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme","volume":"271","author":"Br\u00f6mme","year":"1996","journal-title":"J Biol Chem"},{"issue":"48","key":"2019041200510708200_B32","doi-asserted-by":"crossref","first-page":"32347","DOI":"10.1074\/jbc.273.48.32347","article-title":"The collagenolytic activity of cathepsin K is unique among mammalian proteinases","volume":"273","author":"Garnero","year":"1998","journal-title":"J Biol Chem"},{"issue":"281","key":"2019041200510708200_B33","first-page":"275","article-title":"Structure, expression, and regulation of the major noncollagenous matrix proteins of bone","author":"Young","year":"1992","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"2019041200510708200_B34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/sj.clpt.6100450","article-title":"Cathepsin K inhibitors: a novel target for osteoporosis therapy","volume":"83","author":"Stoch","year":"2008","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"2019041200510708200_B35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/mol.107.039511","article-title":"Effect of cathepsin K inhibitor basicity on in vivo off-target activities","volume":"73","author":"Desmarais","year":"2008","journal-title":"Mol Pharmacol"},{"issue":"5","key":"2019041200510708200_B36","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.bone.2010.01.374","article-title":"The resorptive apparatus of osteoclasts supports lysosomotropism and increases potency of basic versus non-basic inhibitors of cathepsin K","volume":"46","author":"Fuller","year":"2010","journal-title":"Bone"},{"issue":"23","key":"2019041200510708200_B37","doi-asserted-by":"crossref","first-page":"13453","DOI":"10.1073\/pnas.95.23.13453","article-title":"Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice","volume":"95","author":"Saftig","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041200510708200_B38","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1359\/jbmr.1999.14.10.1654","article-title":"Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization","volume":"14","author":"Gowen","year":"1999","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2019041200510708200_B39","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/hmg\/ddl474","article-title":"Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence","volume":"16","author":"Chen","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"6","key":"2019041200510708200_B40","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1359\/jbmr.060313","article-title":"Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass","volume":"21","author":"Li","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2019041200510708200_B41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bone.2004.09.020","article-title":"Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL\/OPG ratio","volume":"36","author":"Kiviranta","year":"2005","journal-title":"Bone"},{"issue":"2","key":"2019041200510708200_B42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bone.2008.08.130","article-title":"Bone density, strength, and formation in adult cathepsin K (\u2212\/\u2212) mice","volume":"44","author":"Pennypacker","year":"2009","journal-title":"Bone"},{"key":"2019041200510708200_B43","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bone.2014.04.032","article-title":"Increased fracture callus mineralization and strength in cathepsin K knockout mice","volume":"66","author":"Gentile","year":"2014","journal-title":"Bone"},{"issue":"6","key":"2019041200510708200_B44","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/S0002-9440(10)63777-7","article-title":"Pivotal role of cathepsin K in lung fibrosis","volume":"164","author":"B\u00fchling","year":"2004","journal-title":"Am J Pathol"},{"key":"2019041200510708200_B45","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1465-9921-9-54","article-title":"Overexpression of cathepsin K in mice decreases collagen deposition and lung resistance in response to bleomycin-induced pulmonary fibrosis","volume":"9","author":"Srivastava","year":"2008","journal-title":"Respir Res"},{"issue":"7","key":"2019041200510708200_B46","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3109\/01902148.2011.581738","article-title":"Cathepsin K deficiency aggravates lung injury in hyperoxia-exposed newborn mice","volume":"37","author":"Knaapi","year":"2011","journal-title":"Exp Lung Res"},{"issue":"8","key":"2019041200510708200_B47","doi-asserted-by":"crossref","first-page":"e683","DOI":"10.1371\/journal.pone.0000683","article-title":"Cathepsin K null mice show reduced adiposity during the rapid accumulation of fat stores","volume":"2","author":"Funicello","year":"2007","journal-title":"PLoS One"},{"issue":"1","key":"2019041200510708200_B48","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.105.561449","article-title":"Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation","volume":"113","author":"Lutgens","year":"2006","journal-title":"Circulation"},{"issue":"2","key":"2019041200510708200_B49","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2337\/db12-0350","article-title":"Cathepsin K knockout mitigates high-fat diet-induced cardiac hypertrophy and contractile dysfunction","volume":"62","author":"Hua","year":"2013","journal-title":"Diabetes"},{"issue":"6","key":"2019041200510708200_B50","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/HYPERTENSIONAHA.111.00947","article-title":"Cathepsin K knockout alleviates pressure overload-induced cardiac hypertrophy","volume":"61","author":"Hua","year":"2013","journal-title":"Hypertension"},{"issue":"2","key":"2019041200510708200_B51","doi-asserted-by":"crossref","first-page":"e0172854","DOI":"10.1371\/journal.pone.0172854","article-title":"Mice, double deficient in lysosomal serine carboxypeptidases Scpep1 and cathepsin A develop the hyperproliferative vesicular corneal dystrophy and hypertrophic skin thickenings","volume":"12","author":"Pan","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"2019041200510708200_B52","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1399-0004.1989.tb03183.x","article-title":"The effect of consanguinity on the reproductive wastage in the Turkish population","volume":"36","author":"Ba\u015faran","year":"1989","journal-title":"Clin Genet"},{"issue":"4","key":"2019041200510708200_B53","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/exd.12920","article-title":"A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis","volume":"25","author":"Yamashita","year":"2016","journal-title":"Exp Dermatol"},{"issue":"3","key":"2019041200510708200_B54","first-page":"1132","article-title":"Cathepsin K in the immunohistochemical diagnosis of melanocytic lesions","volume":"7","author":"Rao","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"2019041200510708200_B55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00441-013-1557-2","article-title":"Cysteine proteases: mode of action and role in epidermal differentiation","volume":"351","author":"Brocklehurst","year":"2013","journal-title":"Cell Tissue Res"},{"issue":"3","key":"2019041200510708200_B56","first-page":"143","article-title":"Cathepsin D expression in chronic plaque psoriasis: an immunohistochemical study","volume":"19","author":"Abdou","year":"2011","journal-title":"Acta Dermatovenerol Croat"},{"issue":"8","key":"2019041200510708200_B57","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1111\/j.1600-0625.2009.00990.x","article-title":"Upregulation of cathepsin S in psoriatic keratinocytes","volume":"19","author":"Sch\u00f6nefuss","year":"2010","journal-title":"Exp Dermatol"},{"issue":"1","key":"2019041200510708200_B58","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaad.2008.03.009","article-title":"Drug-induced morphea: report of a case induced by balicatib and review of the literature","volume":"59","author":"Peroni","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2019041200510708200_B59","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.jaad.2010.11.033","article-title":"Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib","volume":"66","author":"R\u00fcnger","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2019041200510708200_B60","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00223-008-9214-6","article-title":"Ablation of cathepsin k activity in the young mouse causes hypermineralization of long bone and growth plates","volume":"84","author":"Boskey","year":"2009","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"2019041200510708200_B61","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.beem.2014.08.010","article-title":"The clinical spectrum and pathophysiology of skeletal complications in lysosomal storage disorders","volume":"29","author":"Clarke","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2019041200510708200_B62","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.1965.03080090029007","article-title":"The malady of Toulouse-Lautrec","volume":"191","author":"Maroteaux","year":"1965","journal-title":"JAMA"},{"key":"2019041200510708200_B63","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1172-6-20","article-title":"Clinical and animal research findings in pycnodysostosis and gene mutations of cathepsin K from 1996 to 2011","volume":"6","author":"Xue","year":"2011","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"2019041200510708200_B64","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1053\/meta.2001.24924","article-title":"Pycnodysostosis: clinical, radiologic, and endocrine evaluation and linear growth after growth hormone therapy","volume":"50","author":"Soliman","year":"2001","journal-title":"Metabolism"},{"key":"2019041200510708200_B65","first-page":"3453","volume-title":"The Metabolic and Molecular Bases of Inherited Diseases. Vol","author":"Gelb","year":"2000","edition":"8th ed."},{"issue":"2","key":"2019041200510708200_B66","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/ng0695-238","article-title":"The gene for pycnodysostosis maps to human chromosome 1cen-q21","volume":"10","author":"Polymeropoulos","year":"1995","journal-title":"Nat Genet"},{"issue":"2","key":"2019041200510708200_B67","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s004390050177","article-title":"Pycnodysostosis: refined linkage and radiation hybrid analyses reduce the critical region to 2 cM at 1q21 and map two candidate genes","volume":"98","author":"Gelb","year":"1996","journal-title":"Hum Genet"},{"issue":"1","key":"2019041200510708200_B68","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.gene.2013.03.014","article-title":"A novel mutation (R122Q) in the cathepsin K gene in a Chinese child with pyknodysostosis","volume":"521","author":"Zheng","year":"2013","journal-title":"Gene"},{"key":"2019041200510708200_B69","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-9-60","article-title":"Cathepsin K analysis in a pycnodysostosis cohort: demographic, genotypic and phenotypic features","volume":"9","author":"Arman","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"2019041200510708200_B70","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/humu.9490","article-title":"Molecular analysis and characterization of nine novel CTSK mutations in twelve patients affected by pycnodysostosis: mutation in brief #961. Online","volume":"28","author":"Donnarumma","year":"2007","journal-title":"Hum Mutat"},{"issue":"3","key":"2019041200510708200_B71","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/adc.75.3.242","article-title":"Defective growth hormone secretion in children with pycnodysostosis and improved linear growth after growth hormone treatment","volume":"75","author":"Soliman","year":"1996","journal-title":"Arch Dis Child"},{"key":"2019041200510708200_B72","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/ped.12091","article-title":"Novel CTSK mutation resulting in an entire exon 2 skipping in a Thai girl with pycnodysostosis","volume":"55","author":"Utokpat","year":"2013","journal-title":"Pediatr Int"},{"issue":"5","key":"2019041200510708200_B73","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00198-006-0311-y","article-title":"High bone mineral density in pycnodysostotic patients with a novel mutation in the propeptide of cathepsin K","volume":"18","author":"Schilling","year":"2007","journal-title":"Osteoporos Int"},{"issue":"5","key":"2019041200510708200_B74","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1172\/JCI653","article-title":"Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis","volume":"103","author":"Hou","year":"1999","journal-title":"J Clin Invest"},{"key":"2019041200510708200_B75","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1359\/jbmr.080231","article-title":"Mechanisms of the anabolic effects of teriparatide on bone: insight from the treatment of a patient with pycnodysostosis","volume":"23","author":"Chavassieux","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2019041200510708200_B76","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/147323000903700133","article-title":"Molecular analysis of a novel cathepsin K gene mutation in a Chinese child with pycnodysostosis","volume":"37","author":"Li","year":"2009","journal-title":"J Int Med Res"},{"key":"2019041200510708200_B77","doi-asserted-by":"crossref","first-page":"720","DOI":"10.2310\/JIM.0b013e3181da50bd","article-title":"A novel missense mutation in cathepsin K (CTSK) gene in a consanguineous Pakistani family with pycnodysostosis","volume":"58","author":"Khan","year":"2010","journal-title":"J Invest Med"},{"issue":"4","key":"2019041200510708200_B78","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1086\/301795","article-title":"Paternal uniparental disomy for chromosome 1 revealed by molecular analysis of a patient with pycnodysostosis","volume":"62","author":"Gelb","year":"1998","journal-title":"Am J Hum Genet"},{"key":"2019041200510708200_B79","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1359\/jbmr.1999.14.11.1902","article-title":"Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation","volume":"14","author":"Nishi","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2019041200510708200_B80","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2310\/JIM.0b013e318202a9db","article-title":"Familial pycnodysostosis: identification of a novel mutation in the CTSK gene (cathepsin K)","volume":"59","author":"Toral-Lopez","year":"2011","journal-title":"J Invest Med"},{"issue":"6","key":"2019041200510708200_B81","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.ejhg.5200481","article-title":"Cathepsin K gene mutations and 1q21 haplotypes in at patients with pycnodysostosis in an outbred population","volume":"8","author":"Haagerup","year":"2000","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"2019041200510708200_B82","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1002\/ajmg.a.33609","article-title":"Craniosynostosis in pycnodysostosis: broadening the spectrum of the cranial flat bone abnormalities","volume":"152A","author":"Bertola","year":"2010","journal-title":"Am J Med Genet A"},{"issue":"4","key":"2019041200510708200_B83","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1210\/jc.2003-031055","article-title":"Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis","volume":"89","author":"Fratzl-Zelman","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041200510708200_B84","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1210\/jcem.85.1.6247","article-title":"Novel mutations of the cathepsin K gene in patients with pycnodysostosis and their characterization","volume":"85","author":"Fujita","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041200510708200_B85","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/MCD.0b013e3283619632","article-title":"A novel mutation in two families with pycnodysostosis","volume":"22","author":"Ozdemir","year":"2013","journal-title":"Clin Dysmorphol"},{"issue":"5","key":"2019041200510708200_B86","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12098-014-1582-5","article-title":"Novel mutation and white matter involvement in an Indian child with pycnodysostosis","volume":"82","author":"Singh","year":"2015","journal-title":"Indian J Pediatr"},{"issue":"2","key":"2019041200510708200_B87","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0002-9343(66)90108-2","article-title":"Pycnodysostosis, with a familial chromosome anomaly","volume":"40","author":"Elmore","year":"1966","journal-title":"Am J Med"},{"issue":"3","key":"2019041200510708200_B88","first-page":"492","article-title":"Clinical and radiographic maxillofacial features of pycnodysostosis","volume":"7","author":"Alves","year":"2014","journal-title":"Int J Clin Exp Med"},{"issue":"8","key":"2019041200510708200_B89","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/ajmg.a.36557","article-title":"Upper airway surgery of obstructive sleep apnea in pycnodysostosis: case report and literature review","volume":"164A","author":"Testani","year":"2014","journal-title":"Am J Med Genet A"},{"key":"2019041200510708200_B90","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-200590","article-title":"Pycnodysostosis with novel gene mutation and severe obstructive sleep apnoea: management of a complex case","author":"Girbal","year":"2013","journal-title":"BMJ Case Rep"},{"issue":"1","key":"2019041200510708200_B91","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pediatrneurol.2014.09.021","article-title":"Papilledema from craniosynostosis in pycnodysostosis","volume":"52","author":"Kyung","year":"2015","journal-title":"Pediatr Neurol"},{"issue":"11","key":"2019041200510708200_B92","first-page":"3915","article-title":"Molecular and clinical analysis in a series of patients with pyknodysostosis reveals some uncommon phenotypic findings","volume":"7","author":"Valdes-Flores","year":"2014","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"2019041200510708200_B93","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4103\/0976-3147.133606","article-title":"A patient with pycnodysostosis presenting with seizures and porencephalic cysts","volume":"5","author":"Kumar","year":"2014","journal-title":"J Neurosci Rural Pract"},{"issue":"7","key":"2019041200510708200_B94","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/MPH.0b013e31826157b1","article-title":"A case of osteosarcoma in a patient with pycnodysostosis","volume":"34","author":"Cortisse","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"key":"2019041200510708200_B95","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bone.2013.11.014","article-title":"Exome sequencing identifies CTSK mutations in patients originally diagnosed as intermediate osteopetrosis","volume":"59","author":"Pangrazio","year":"2014","journal-title":"Bone"},{"key":"2019041200510708200_B96","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/jbmr.308","article-title":"An atypical subtrochanteric femoral fracture from pycnodysostosis: a lesson from nature","volume":"26","author":"Yates","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2019041200510708200_B97","first-page":"769","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"Whyte"},{"issue":"2","key":"2019041200510708200_B98","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/er.2006-0029","article-title":"Insights into material and structural basis of bone fragility from diseases associated with fractures: how determinants of the biomechanical properties of bone are compromised by disease","volume":"28","author":"Chavassieux","year":"2007","journal-title":"Endocr Rev"},{"issue":"6","key":"2019041200510708200_B99","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1210\/jc.2009-2531","article-title":"Near normalization of adult height and body proportions by growth hormone in pycnodysostosis","volume":"95","author":"Rothenb\u00fchler","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041200510708200_B100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/BPB.0b013e328341bc6a","article-title":"Fracture management in pycnodysostosis: 27 years of follow-up","volume":"20","author":"Bor","year":"2011","journal-title":"J Pediatr Orthop B"},{"issue":"3","key":"2019041200510708200_B101","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00402-006-0270-y","article-title":"Surgical outcomes after treatment of fractures in femur and tibia in pycnodysostosis","volume":"127","author":"Nakase","year":"2007","journal-title":"Arch Orthop Trauma Surg"},{"key":"2019041200510708200_B102","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1007\/s00198-015-3191-1","article-title":"Atypical femur fractures in a patient with pycnodysostosis: a case report","volume":"26","author":"Hashem","year":"2015","journal-title":"Osteoporosis Int"},{"issue":"2","key":"2019041200510708200_B103","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bjps.2004.10.023","article-title":"Mandibular osteomyelitis and fracture successfully treated with vascularised iliac bone graft in a patient with pycnodysostosis","volume":"58","author":"Kato","year":"2005","journal-title":"Br J Plast Surg"},{"issue":"6","key":"2019041200510708200_B104","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00774-013-0542-x","article-title":"ONO-5334, a cathepsin K inhibitor, improves bone strength by preferentially increasing cortical bone mass in ovariectomized rats","volume":"32","author":"Ochi","year":"2014","journal-title":"J Bone Miner Metab"},{"issue":"4","key":"2019041200510708200_B105","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1128\/IAI.01713-14","article-title":"A small molecule, odanacatib, inhibits inflammation and bone loss caused by endodontic disease","volume":"83","author":"Hao","year":"2015","journal-title":"Infect Immun"},{"issue":"8","key":"2019041200510708200_B106","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1902\/jop.2015.140643","article-title":"Odanacatib, a cathepsin K-specific inhibitor, inhibits inflammation and bone loss caused by periodontal diseases","volume":"86","author":"Hao","year":"2015","journal-title":"J Periodontol"},{"key":"2019041200510708200_B107","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/jbmr.223","article-title":"Cathepsin K inhibitors prevent bone loss in estrogen-deficient rabbits","volume":"26","author":"Pennypacker","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2019041200510708200_B108","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jbmr.2719","article-title":"Odanacatib restores trabecular bone of skeletally mature female rabbits with osteopenia but induces brittleness of cortical bone: a comparative study of the investigational drug with PTH, estrogen and alendronate","volume":"31","author":"Khan","year":"2016","journal-title":"J Bone Miner Res"},{"key":"2019041200510708200_B109","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/1471-2474-14-344","article-title":"Cathepsin K inhibitors increase distal femoral bone mineral density in rapidly growing rabbits","volume":"14","author":"Pennypacker","year":"2013","journal-title":"BMC Musculoskelet Disord"},{"key":"2019041200510708200_B110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jor.22982","article-title":"Odanacatib increases mineralized callus during fracture healing in a rabbit ulnar osteotomy model","volume":"34","author":"Pennypacker","year":"2016","journal-title":"J Orthop Res"},{"issue":"1","key":"2019041200510708200_B111","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bone.2006.07.015","article-title":"A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys","volume":"40","author":"Kumar","year":"2007","journal-title":"Bone"},{"issue":"4","key":"2019041200510708200_B112","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00223-009-9279-x","article-title":"Treatment with a potent cathepsin K inhibitor preserves cortical and trabecular bone mass in ovariectomized monkeys","volume":"85","author":"Stroup","year":"2009","journal-title":"Calcif Tissue Int"},{"issue":"24","key":"2019041200510708200_B113","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1021\/jm0504961","article-title":"Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity","volume":"48","author":"Falgueyret","year":"2005","journal-title":"J Med Chem"},{"key":"2019041200510708200_B114","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1007\/s00198-011-1529-x","article-title":"Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys","volume":"22","author":"Jerome","year":"2011","journal-title":"Osteoporosis Int"},{"key":"2019041200510708200_B115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2014.04.023","article-title":"Effects of eight-month treatment with ONO-5334, a cathepsin K inhibitor, on bone metabolism, strength and microstructure in ovariectomized cynomolgus monkeys","volume":"65","author":"Ochi","year":"2014","journal-title":"Bone"},{"issue":"9-10","key":"2019041200510708200_B116","first-page":"499","article-title":"Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption","volume":"52","author":"Halleen","year":"2006","journal-title":"Clin Lab"},{"key":"2019041200510708200_B117","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/jbmr.1477","article-title":"Odanacatib treatment increases hip bone mass and cortical thickness by preserving endocortical bone formation and stimulating periosteal bone formation in the ovariectomized adult rhesus monkey","volume":"27","author":"Cusick","year":"2012","journal-title":"J Bone Miner Res"},{"key":"2019041200510708200_B118","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jbmr.1475","article-title":"Odanacatib reduces bone turnover and increases bone mass in the lumbar spine of skeletally mature ovariectomized rhesus monkeys","volume":"27","author":"Masarachia","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2019041200510708200_B119","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.bone.2012.03.017","article-title":"Evaluation of high-resolution peripheral quantitative computed tomography, finite element analysis and biomechanical testing in a pre-clinical model of osteoporosis: a study with odanacatib treatment in the ovariectomized adult rhesus monkey","volume":"50","author":"Jayakar","year":"2012","journal-title":"Bone"},{"issue":"3","key":"2019041200510708200_B120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00223-012-9673-7","article-title":"Effects of odanacatib on bone mineralization density distribution in thoracic spine and femora of ovariectomized adult rhesus monkeys: a quantitative backscattered electron imaging study","volume":"92","author":"Fratzl-Zelman","year":"2013","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"2019041200510708200_B121","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bone.2013.06.011","article-title":"High-resolution peripheral quantitative computed tomography and finite element analysis of bone strength at the distal radius in ovariectomized adult rhesus monkey demonstrate efficacy of odanacatib and differentiation from alendronate","volume":"56","author":"Cabal","year":"2013","journal-title":"Bone"},{"issue":"2","key":"2019041200510708200_B122","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bone.2013.06.008","article-title":"Effect of odanacatib on bone turnover markers, bone density and geometry of the spine and hip of ovariectomized monkeys: a head-to-head comparison with alendronate","volume":"56","author":"Williams","year":"2013","journal-title":"Bone"},{"key":"2019041200510708200_B123","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/jbmr.2211","article-title":"Inhibition of cathepsin K increases modeling-based bone formation, and improves cortical dimension and strength in adult ovariectomized monkeys","volume":"29","author":"Pennypacker","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2019041200510708200_B124","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/1759720X13490860","article-title":"Odanacatib in postmenopausal women with low bone mineral density: a review of current clinical evidence","volume":"5","author":"Zerbini","year":"2013","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2019041200510708200_B125","article-title":"Effect of one year treatment with the cathepsin-K inhibitor, balicatib, on bone mineral density (BMD) in postmenopausal women with osteopenia\/osteoporosis","volume":"21","author":"Adami S","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2019041200510708200_B126","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/clpt.2009.60","article-title":"Effect of the cathepsin K inhibitor odanacatib on bone resorption biomarkers in healthy postmenopausal women: two double-blind, randomized, placebo-controlled phase I studies","volume":"86","author":"Stoch","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"2019041200510708200_B127","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/j.1365-2125.2012.04471.x","article-title":"Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics\u2014results from single oral dose studies in healthy volunteers","volume":"75","author":"Stoch","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"2019041200510708200_B128","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/jbmr.341","article-title":"Safety and efficacy of the cathepsin K inhibitor ONO-5334 in postmenopausal osteoporosis: the OCEAN study","volume":"26","author":"Eastell","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2019041200510708200_B129","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/jbmr.2047","article-title":"Effect of ONO-5334 on bone mineral density and biochemical markers of bone turnover in postmenopausal osteoporosis: 2-year results from the OCEAN study","volume":"29","author":"Eastell","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2019041200510708200_B130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00774-013-0558-2","article-title":"Bone turnover markers and pharmacokinetics of a new sustained-release formulation of the cathepsin K inhibitor, ONO-5334, in healthy post-menopausal women","volume":"33","author":"Nagase","year":"2015","journal-title":"J Bone Miner Metab"},{"key":"2019041200510708200_B131","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1359\/jbmr.091035","article-title":"danacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density","volume":"25","author":"Bone","year":"2010","journal-title":"J Bone Miner Res"},{"key":"2019041200510708200_B132","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jbmr.212","article-title":"Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect","volume":"26","author":"Eisman","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2019041200510708200_B133","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/jbmr.1695","article-title":"Odanacatib in the treatment of postmenopausal women with low bone mineral density: five years of continued therapy in a phase 2 study","volume":"27","author":"Langdahl","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2019041200510708200_B134","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1007\/s00198-016-3503-0","article-title":"Continuous treatment with odanacatib for up to 8\u00a0years in postmenopausal women with low bone mineral density: a phase 2 study","volume":"27","author":"Rizzoli","year":"2016","journal-title":"Osteoporos Int"},{"key":"2019041200510708200_B135","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00198-013-2398-2","article-title":"Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis\u2014a double-blind, randomized, dose-finding study","volume":"25","author":"Nakamura","year":"2014","journal-title":"Osteoporosis Int"},{"issue":"2","key":"2019041200510708200_B136","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1210\/jc.2013-1688","article-title":"Odanacatib, a selective cathepsin K inhibitor, demonstrates comparable pharmacodynamics and pharmacokinetics in older men and postmenopausal women","volume":"99","author":"Anderson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2019041200510708200_B137","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1210\/jc.2013-2020","article-title":"Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial","volume":"98","author":"Bonnick","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041200510708200_B138","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3816\/CBC.2010.n.059","article-title":"The cathepsin K inhibitor odanacatib suppresses bone resorption in women with breast cancer and established bone metastases: results of a 4-week, double-blind, randomized, controlled trial","volume":"10","author":"Jensen","year":"2010","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"2019041200510708200_B139","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1210\/jc.2012-2972","article-title":"Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial","volume":"98","author":"Brixen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041200510708200_B140"},{"key":"2019041200510708200_B141","first-page":"30","article-title":"Odanacatib treatment affects trabecular and cortical bone in the femur of postmenopausal women: results of a two-year placebo-controlled trial","volume-title":"J Bone Miner Res","author":"Engelke","year":"2015"},{"issue":"2","key":"2019041200510708200_B142","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00198-014-2944-6","article-title":"Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial","volume":"26","author":"Bone","year":"2015","journal-title":"Osteoporos Int"},{"issue":"3","key":"2019041200510708200_B143","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1759720X15580903","article-title":"Odanacatib: a review of its potential in the management of osteoporosis in postmenopausal women","volume":"7","author":"Chapurlat","year":"2015","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2019041200510708200_B144"},{"key":"2019041200510708200_B145"},{"key":"2019041200510708200_B146"},{"key":"2019041200510708200_B147"},{"key":"2019041200510708200_B148","volume-title":"Safety of odanacatib in postmenopausal women with osteoporosis: 5-year data from the extension of the phase 3 Long-Term Odanacatib Fracture Trial (LOFT)","author":"Papapoulos","year":"2016"},{"key":"2019041200510708200_B149"},{"key":"2019041200510708200_B150","volume-title":"The Long-Term Odanacatib Fracture Trial (LOFT): cardiovascular safety results","author":"O\u2019Donoghue","year":"2016"},{"issue":"1","key":"2019041200510708200_B151","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1615\/CritRevEukarGeneExpr.v19.i1.40","article-title":"Molecular mechanisms in coupling of bone formation to resorption","volume":"19","author":"Martin","year":"2009","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"2","key":"2019041200510708200_B152","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molmed.2004.12.004","article-title":"Osteoclast-derived activity in the coupling of bone formation to resorption","volume":"11","author":"Martin","year":"2005","journal-title":"Trends Mol Med"},{"key":"2019041200510708200_B153","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/bonekey.2013.215","article-title":"Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit","volume":"3","author":"Sims","year":"2014","journal-title":"Bonekey Rep"},{"key":"2019041200510708200_B154","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fendo.2015.00041","article-title":"Coupling signals between the osteoclast and osteoblast: how are messages transmitted between these temporary visitors to the bone surface?","volume":"6","author":"Sims","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2019041200510708200_B155","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s00223-013-9741-7","article-title":"Osteoclast-derived coupling factors in bone remodeling","volume":"94","author":"Henriksen","year":"2014","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"2019041200510708200_B156","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/jbmr.2276","article-title":"Coupling factors: how many candidates can there be?","volume":"29","author":"Martin","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2019041200510708200_B157","doi-asserted-by":"crossref","first-page":"163","DOI":"10.11005\/jbm.2014.21.3.163","article-title":"Factors and mechanisms involved in the coupling from bone resorption to formation: how osteoclasts talk to osteoblasts","volume":"21","author":"Ikeda","year":"2014","journal-title":"J Bone Metab"},{"key":"2019041200510708200_B158","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/bonekey.2014.56","article-title":"The reversal phase of the bone-remodeling cycle: cellular prerequisites for coupling resorption and formation","volume":"3","author":"Delaisse","year":"2014","journal-title":"Bonekey Rep"},{"issue":"1","key":"2019041200510708200_B159","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1210\/jc.2002-021036","article-title":"Differential effects of androgens and estrogens on bone turnover in normal men","volume":"88","author":"Leder","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041200510708200_B160","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm.1954","article-title":"Inhibition of osteoblastic bone formation by nuclear factor-kappaB","volume":"15","author":"Chang","year":"2009","journal-title":"Nat Med"},{"issue":"7","key":"2019041200510708200_B161","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1359\/jbmr.1998.13.7.1124","article-title":"Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability","volume":"13","author":"Hannon","year":"1998","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2019041200510708200_B162","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1172\/JCI10942","article-title":"Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men","volume":"106","author":"Falahati-Nini","year":"2000","journal-title":"J Clin Invest"},{"issue":"12","key":"2019041200510708200_B163","doi-asserted-by":"crossref","first-page":"E725","DOI":"10.1073\/pnas.1120735109","article-title":"Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH","volume":"109","author":"Bedi","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"2019041200510708200_B164","doi-asserted-by":"crossref","first-page":"e12290","DOI":"10.1371\/journal.pone.0012290","article-title":"Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss","volume":"5","author":"Tawfeek","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"2019041200510708200_B165","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bone.2010.04.611","article-title":"T cells: critical bone regulators in health and disease","volume":"47","author":"Pacifici","year":"2010","journal-title":"Bone"},{"issue":"9","key":"2019041200510708200_B166","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1359\/jbmr.2001.16.9.1575","article-title":"Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers","volume":"16","author":"Hauge","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2019041200510708200_B167","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2353\/ajpath.2009.080627","article-title":"A physical mechanism for coupling bone resorption and formation in adult human bone","volume":"174","author":"Andersen","year":"2009","journal-title":"Am J Pathol"},{"issue":"2","key":"2019041200510708200_B168","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1172\/JCI33612","article-title":"Building bone to reverse osteoporosis and repair fractures","volume":"118","author":"Khosla","year":"2008","journal-title":"J Clin Invest"},{"issue":"1","key":"2019041200510708200_B169","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1359\/jbmr.2000.15.1.60","article-title":"Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo","volume":"15","author":"Verborgt","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2019041200510708200_B170","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.bone.2006.12.064","article-title":"Characterization of circulating osteoblast lineage cells in humans","volume":"40","author":"Eghbali-Fatourechi","year":"2007","journal-title":"Bone"},{"issue":"19","key":"2019041200510708200_B171","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa044264","article-title":"Circulating osteoblast-lineage cells in humans","volume":"352","author":"Eghbali-Fatourechi","year":"2005","journal-title":"N Engl J Med"},{"issue":"10","key":"2019041200510708200_B172","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1002\/jbmr.1665","article-title":"Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts","volume":"27","author":"Kim","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2019041200510708200_B173","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1359\/jbmr.1998.13.11.1760","article-title":"Mechanical loading stimulates bone formation by reactivation of bone lining cells in 13-week-old rats","volume":"13","author":"Chow","year":"1998","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2019041200510708200_B174","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/endo.136.8.7628403","article-title":"Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells","volume":"136","author":"Dobnig","year":"1995","journal-title":"Endocrinology"},{"issue":"3","key":"2019041200510708200_B175","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/jbmr.1760","article-title":"Increased presence of capillaries next to remodeling sites in adult human cancellous bone","volume":"28","author":"Kristensen","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2019041200510708200_B176","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","article-title":"The molecular understanding of osteoclast differentiation","volume":"40","author":"Asagiri","year":"2007","journal-title":"Bone"},{"issue":"2","key":"2019041200510708200_B177","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ar.10121","article-title":"Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin","volume":"268","author":"Shiotani","year":"2002","journal-title":"Anat Rec"},{"key":"2019041200510708200_B178","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/0470846658.ch16","article-title":"The molecular basis of osteoclast differentiation and activation","volume":"232","author":"Suda","year":"2001","journal-title":"Novartis Found Symp"},{"key":"2019041200510708200_B179","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/jcb.10614","article-title":"Differentiation potential of a mouse bone marrow stromal cell line","volume":"90","author":"Allan","year":"2003","journal-title":"J Cell Biochem"},{"issue":"2","key":"2019041200510708200_B180","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1172\/JCI40568","article-title":"Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice","volume":"120","author":"Walker","year":"2010","journal-title":"J Clin Invest"},{"issue":"11","key":"2019041200510708200_B181","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1002\/jbmr.465","article-title":"Cell line IDG-SW3 replicates osteoblast-to-late-osteocyte differentiation in vitro and accelerates bone formation in vivo","volume":"26","author":"Woo","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2019041200510708200_B182","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1210\/edrv-6-4-544","article-title":"Local regulators of skeletal growth: a perspective","volume":"6","author":"Centrella","year":"1985","journal-title":"Endocr Rev"},{"issue":"7","key":"2019041200510708200_B183","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1073\/pnas.84.7.2024","article-title":"Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones","volume":"84","author":"Pfeilschifter","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2019041200510708200_B184","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0006-291X(89)92795-2","article-title":"Activation of the bone-derived latent TGF beta complex by isolated osteoclasts","volume":"158","author":"Oreffo","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"2019041200510708200_B185","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/jbmr.5650090402","article-title":"Osteoclast synthesis and secretion and activation of latent transforming growth factor beta","volume":"9","author":"Oursler","year":"1994","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2019041200510708200_B186","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nm.1979","article-title":"TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation","volume":"15","author":"Tang","year":"2009","journal-title":"Nat Med"},{"issue":"7","key":"2019041200510708200_B187","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/nm.2793","article-title":"Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells","volume":"18","author":"Xian","year":"2012","journal-title":"Nat Med"},{"issue":"4","key":"2019041200510708200_B188","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1359\/jbmr.070109","article-title":"Are nonresorbing osteoclasts sources of bone anabolic activity?","volume":"22","author":"Karsdal","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2019041200510708200_B189","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1083\/jcb.151.2.311","article-title":"Decreased c-Src expression enhances osteoblast differentiation and bone formation","volume":"151","author":"Marzia","year":"2000","journal-title":"J Cell Biol"},{"issue":"2","key":"2019041200510708200_B190","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(01)00206-9","article-title":"Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man","volume":"104","author":"Kornak","year":"2001","journal-title":"Cell"},{"issue":"4","key":"2019041200510708200_B191","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0092-8674(91)90499-O","article-title":"Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice","volume":"64","author":"Soriano","year":"1991","journal-title":"Cell"},{"issue":"4","key":"2019041200510708200_B192","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/jmg.2005.036673","article-title":"Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment","volume":"43","author":"Del Fattore","year":"2006","journal-title":"J Med Genet"},{"issue":"25","key":"2019041200510708200_B193","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1093\/hmg\/10.25.2861","article-title":"Albers-Sch\u00f6nberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene","volume":"10","author":"Cleiren","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2019041200510708200_B194","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bone.2012.06.007","article-title":"A specific subtype of osteoclasts secretes factors inducing nodule formation by osteoblasts","volume":"51","author":"Henriksen","year":"2012","journal-title":"Bone"},{"issue":"9","key":"2019041200510708200_B195","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1359\/JBMR.040514","article-title":"Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone","volume":"19","author":"Dai","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"7-8","key":"2019041200510708200_B196","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.micron.2005.06.008","article-title":"Reduced osteoblastic population and defective mineralization in osteopetrotic (op\/op) mice","volume":"36","author":"Sakagami","year":"2005","journal-title":"Micron"},{"issue":"10","key":"2019041200510708200_B197","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1359\/jbmr.2000.15.10.1905","article-title":"Mineral density and bone strength are dissociated in long bones of rat osteopetrotic mutations","volume":"15","author":"Tuukkanen","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2019041200510708200_B198","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1210\/er.2010-0006","article-title":"Osteoclast activity and subtypes as a function of physiology and pathology\u2014implications for future treatments of osteoporosis","volume":"32","author":"Henriksen","year":"2011","journal-title":"Endocr Rev"},{"issue":"27","key":"2019041200510708200_B199","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1056\/NEJMra040952","article-title":"Osteopetrosis","volume":"351","author":"Tolar","year":"2004","journal-title":"N Engl J Med"},{"issue":"13","key":"2019041200510708200_B200","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/hmg\/9.13.2059","article-title":"Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis","volume":"9","author":"Kornak","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2019041200510708200_B201","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/77131","article-title":"Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis","volume":"25","author":"Frattini","year":"2000","journal-title":"Nat Genet"},{"issue":"6","key":"2019041200510708200_B202","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/8756-3282(93)90316-3","article-title":"Ultrastructural investigations of bone resorptive cells in two types of autosomal dominant osteopetrosis","volume":"14","author":"Bollerslev","year":"1993","journal-title":"Bone"},{"issue":"5","key":"2019041200510708200_B203","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1373\/clinchem.2003.029355","article-title":"Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis)","volume":"50","author":"Alatalo","year":"2004","journal-title":"Clin Chem"},{"issue":"1","key":"2019041200510708200_B204","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajhg.2008.06.015","article-title":"Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations","volume":"83","author":"Guerrini","year":"2008","journal-title":"Am J Hum Genet"},{"issue":"52","key":"2019041200510708200_B205","doi-asserted-by":"crossref","first-page":"20764","DOI":"10.1073\/pnas.0805133106","article-title":"Regulation of bone formation by osteoclasts involves Wnt\/BMP signaling and the chemokine sphingosine-1-phosphate","volume":"105","author":"Pederson","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2019041200510708200_B206","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1210\/en.2013-1272","article-title":"TGF-\u03b2 induces Wnt10b in osteoclasts from female mice to enhance coupling to osteoblasts","volume":"154","author":"Ota","year":"2013","journal-title":"Endocrinology"},{"issue":"24","key":"2019041200510708200_B207","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1038\/sj.emboj.7601430","article-title":"Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling","volume":"25","author":"Ryu","year":"2006","journal-title":"EMBO J"},{"issue":"8","key":"2019041200510708200_B208","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.1074\/jbc.M112.413583","article-title":"Sphingosine 1-phosphate (S1P) receptors 1 and 2 coordinately induce mesenchymal cell migration through S1P activation of complementary kinase pathways","volume":"288","author":"Quint","year":"2013","journal-title":"J Biol Chem"},{"issue":"13","key":"2019041200510708200_B209","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1084\/jem.20101474","article-title":"Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo","volume":"207","author":"Ishii","year":"2010","journal-title":"J Exp Med"},{"issue":"2","key":"2019041200510708200_B210","first-page":"666","article-title":"Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation","volume":"123","author":"Lotinun","year":"2013","journal-title":"J Clin Invest"},{"issue":"2","key":"2019041200510708200_B211","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jcb.22406","article-title":"Non-resorbing osteoclasts induce migration and osteogenic differentiation of mesenchymal stem cells","volume":"109","author":"Kreja","year":"2010","journal-title":"J Cell Biochem"},{"issue":"10","key":"2019041200510708200_B212","doi-asserted-by":"crossref","first-page":"e3537","DOI":"10.1371\/journal.pone.0003537","article-title":"Osteoclasts control osteoblast chemotaxis via PDGF-BB\/PDGF receptor beta signaling","volume":"3","author":"Sanchez-Fernandez","year":"2008","journal-title":"PLoS One"},{"issue":"2","key":"2019041200510708200_B213","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1359\/jbmr.2002.17.2.257","article-title":"Platelet-derived growth factor BB secreted from osteoclasts acts as an osteoblastogenesis inhibitory factor","volume":"17","author":"Kubota","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2019041200510708200_B214","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1359\/jbmr.080706","article-title":"Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling","volume":"23","author":"Walker","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2019041200510708200_B215","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bone.2012.06.015","article-title":"Afamin secreted from nonresorbing osteoclasts acts as a chemokine for preosteoblasts via the Akt-signaling pathway","volume":"51","author":"Kim","year":"2012","journal-title":"Bone"},{"issue":"9","key":"2019041200510708200_B216","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1172\/JCI69493","article-title":"Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation","volume":"123","author":"Takeshita","year":"2013","journal-title":"J Clin Invest"},{"issue":"7396","key":"2019041200510708200_B217","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nature11000","article-title":"Osteoprotection by semaphorin 3A","volume":"485","author":"Hayashi","year":"2012","journal-title":"Nature"},{"issue":"7450","key":"2019041200510708200_B218","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature12115","article-title":"Sema3A regulates bone-mass accrual through sensory innervations","volume":"497","author":"Fukuda","year":"2013","journal-title":"Nature"},{"issue":"6","key":"2019041200510708200_B219","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/ncb1416","article-title":"Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis","volume":"8","author":"Takegahara","year":"2006","journal-title":"Nat Cell Biol"},{"issue":"Pt 14","key":"2019041200510708200_B220","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1242\/jcs.00625","article-title":"\u201cEph\u201dective signaling: forward, reverse and crosstalk","volume":"116","author":"Murai","year":"2003","journal-title":"J Cell Sci"},{"issue":"2","key":"2019041200510708200_B221","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cmet.2006.05.012","article-title":"Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis","volume":"4","author":"Zhao","year":"2006","journal-title":"Cell Metab"},{"issue":"8","key":"2019041200510708200_B222","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1359\/jbmr.080324","article-title":"EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts","volume":"23","author":"Allan","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2019041200510708200_B223","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/nm.2489","article-title":"Suppression of bone formation by osteoclastic expression of semaphorin 4D","volume":"17","author":"Negishi-Koga","year":"2011","journal-title":"Nat Med"},{"issue":"8","key":"2019041200510708200_B224","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMe0905480","article-title":"Increasing options for the treatment of osteoporosis","volume":"361","author":"Khosla","year":"2009","journal-title":"N Engl J Med"},{"key":"2019041200510708200_B225","first-page":"412","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"Papapoulos","edition":"8th ed"},{"issue":"3","key":"2019041200510708200_B226","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/jbmr.1541","article-title":"Odanacatib: location and timing are everything","volume":"27","author":"Khosla","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2019041200510708200_B227","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/jbmr.5650071216","article-title":"Bone resorption and formation on the periosteal envelope of the ilium: a histomorphometric study in healthy women","volume":"7","author":"Balena","year":"1992","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2019041200510708200_B228","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1359\/jbmr.060414","article-title":"Periosteal remodeling at the femoral neck in nonhuman primates","volume":"21","author":"Bliziotes","year":"2006","journal-title":"J Bone Miner Res"},{"key":"2019041200510708200_B229","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"key":"2019041200510708200_B230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"J Bone Miner Res"},{"key":"2019041200510708200_B231","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jbmr.2708","article-title":"Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research","volume":"31","author":"Adler","year":"2016","journal-title":"J Bone Miner Res"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/38\/4\/325\/19497223\/er.2015-1114.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T23:26:33Z","timestamp":1719271593000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/38\/4\/325\/3885828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,23]]},"references-count":231,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,6,23]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2015-1114","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8,1]]},"published":{"date-parts":[[2017,6,23]]}}}